TY  - JOUR
AU  - Remon, J
AU  - Bernabé, R
AU  - Diz, P
AU  - Felip, E
AU  - González-Larriba, J L
AU  - Lázaro, M
AU  - Mielgo-Rubio, X
AU  - Sánchez, A
AU  - Sullivan, I
AU  - Massutti, B
PY  - 2022
DO  - 10.1007/s12094-022-02788-w
UR  - http://hdl.handle.net/10668/21041
T2  - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AB  - Thymic epithelial tumours (TET) represent a heterogeneous group of rare malignancies that include thymomas and thymic carcinoma. Treatment of TET is based on the resectability of the tumour. If this is considered achievable upfront, surgical resection...
LA  - en
KW  - Chemotherapy
KW  - Lenvatinib
KW  - Multidisciplinary
KW  - Nivolumab
KW  - Thymic epithelial tumours
KW  - Humans
KW  - Neoplasms, Glandular and Epithelial
KW  - Prospective Studies
KW  - Thymoma
KW  - Thymus Neoplasms
TI  - SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021).
TY  - research article
VL  - 24
ER  -